TATA Health International Holdings Limited

SEHK:1255 Stock Report

Market Cap: HK$72.9m

TATA Health International Holdings Past Earnings Performance

Past criteria checks 0/6

TATA Health International Holdings has been growing earnings at an average annual rate of 2.6%, while the Specialty Retail industry saw earnings declining at 0.8% annually. Revenues have been declining at an average rate of 24.3% per year.

Key information

2.6%

Earnings growth rate

3.6%

EPS growth rate

Specialty Retail Industry Growth1.1%
Revenue growth rate-24.3%
Return on equity-417.4%
Net Margin-12.4%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Pinning Down TATA Health International Holdings Limited's (HKG:1255) P/S Is Difficult Right Now

Mar 01
Pinning Down TATA Health International Holdings Limited's (HKG:1255) P/S Is Difficult Right Now

Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?

Nov 02
Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?

TATA Health International Holdings Limited's (HKG:1255) Business Is Trailing The Industry But Its Shares Aren't

Aug 04
TATA Health International Holdings Limited's (HKG:1255) Business Is Trailing The Industry But Its Shares Aren't

Does TATA Health International Holdings (HKG:1255) Have A Healthy Balance Sheet?

Apr 09
Does TATA Health International Holdings (HKG:1255) Have A Healthy Balance Sheet?

Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?

Sep 16
Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?

Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?

Nov 07
Is TATA Health International Holdings (HKG:1255) Using Too Much Debt?

Revenue & Expenses Breakdown

How TATA Health International Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:1255 Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23185-231750
31 Mar 23165-71590
31 Dec 22145101440
30 Sep 22148-21500
30 Jun 22151-141550
31 Mar 22156-371590
31 Dec 21161-611630
30 Sep 21155-771640
30 Jun 21149-941650
31 Mar 21152-1231740
31 Dec 20155-1521830
30 Sep 20192-1471980
30 Jun 20229-1432130
31 Mar 20285-1022250
31 Dec 19342-612370
30 Sep 19357-332320
30 Jun 19373-42270
31 Mar 19366-32230
31 Dec 18358-22200
30 Sep 18387-122340
30 Jun 18417-232490
31 Mar 18450-332720
31 Dec 17484-432950
30 Sep 17503-403130
30 Jun 17523-363300
31 Mar 17543-353420
31 Dec 16562-343540
30 Sep 16568-333600
30 Jun 16574-313650
31 Mar 16568-243630
31 Dec 15561-163610
30 Sep 15565-113620
30 Jun 15568-63630
31 Mar 1557913610
31 Dec 1459193590
30 Sep 14589143510
30 Jun 14587183430
31 Mar 14568173330
31 Dec 13550173230
30 Sep 13536213140
30 Jun 13523253040

Quality Earnings: 1255 is currently unprofitable.

Growing Profit Margin: 1255 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1255 is unprofitable, but has reduced losses over the past 5 years at a rate of 2.6% per year.

Accelerating Growth: Unable to compare 1255's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1255 is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (11.2%).


Return on Equity

High ROE: 1255 has a negative Return on Equity (-417.39%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/25 10:09
End of Day Share Price 2024/03/28 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TATA Health International Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution